Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $991.80 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $651.61 | 6 | $0 (2017) |
| GlaxoSmithKline, LLC. | $121.81 | 1 | $0 (2017) |
| Abbott Laboratories | $97.90 | 1 | $0 (2017) |
| Synergy Pharmaceuticals Inc | $96.43 | 2 | $0 (2018) |
| Lundbeck LLC | $24.05 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $120.48 | 3 | Synergy Pharmaceuticals Inc ($96.43) |
| 2017 | $871.32 | 8 | Janssen Pharmaceuticals, Inc ($651.61) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/15/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $73.53 | General |
| Category: Gastroenterology | ||||||
| 05/15/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $22.90 | General |
| Category: Gastroenterology | ||||||
| 02/06/2018 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $24.05 | General |
| Category: NEUROLOGY | ||||||
| 10/12/2017 | Abbott Laboratories | FreeStyle Libre Pro (Device), FreeStyle Libre Pro, FreeStyle Libre Pro | Food and Beverage | In-kind items and services | $97.90 | General |
| Category: Diabetes Care | ||||||
| 08/08/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $110.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/01/2017 | GlaxoSmithKline, LLC. | INCRUSE (Drug) | Food and Beverage | In-kind items and services | $121.81 | General |
| Category: RESPIRATORY | ||||||
| 06/07/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $87.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/31/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $106.35 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $102.55 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/11/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $123.17 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Cardiovascular & Metabolism | ||||||
About Dr. Abdul Razzaq, MD
Dr. Abdul Razzaq, MD is a Internal Medicine healthcare provider based in Villa Park, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1760470314.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abdul Razzaq, MD has received a total of $991.80 in payments from pharmaceutical and medical device companies, with $120.48 received in 2018. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($991.80).
Practice Information
- Specialty Internal Medicine
- Location Villa Park, IL
- Active Since 10/07/2005
- Last Updated 03/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1760470314
Products in Payments
- XARELTO (Drug) $338.73
- INVOKANA (Drug) $312.88
- INCRUSE (Drug) $121.81
- FreeStyle Libre Pro (Device) $97.90
- Trulance (Drug) $96.43
- NORTHERA (Drug) $24.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.